Medicover reported strong fourth-quarter results, with revenue rising 10.6% to €611.7 million and operating profit surging 50.3% to €35.2 million. The company’s net profit more than doubled to €17.3 million, translating to €0.124 per share. This performance, driven by organic growth and strategic acquisitions, led to a dividend increase to €0.20 per share, up from €0.15.

The healthcare and diagnostic services provider highlighted robust demand for its services, with Healthcare Services revenue up 8.5% and Diagnostic Services revenue rising 13.5%. Medicover’s CEO, John Stubbington, emphasized the achievement of three-year financial targets for 2023-2025 and outlined ambitious 2026-2028 goals, including €3.25 billion in organic revenue and €600 million in EBITDA. The stock rose 1.7% following the announcement.